- Home
- CNTX vs ABVE Comparison
CNTX vs ABVE Comparison
Compare CNTX & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- ABVE
- Stock Information
- Founded
- CNTX 2015
- ABVE 2019
- Country
- CNTX United States
- ABVE Canada
- Employees
- CNTX N/A
- ABVE N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- ABVE Packaged Foods
- Sector
- CNTX Health Care
- ABVE Consumer Staples
- Exchange
- CNTX Nasdaq
- ABVE Nasdaq
- Market Cap
- CNTX 75.6M
- ABVE 90.1M
- IPO Year
- CNTX 2021
- ABVE N/A
- Fundamental
- Price
- CNTX $0.82
- ABVE $1.67
- Analyst Decision
- CNTX Strong Buy
- ABVE
- Analyst Count
- CNTX 5
- ABVE 0
- Target Price
- CNTX $5.25
- ABVE N/A
- AVG Volume (30 Days)
- CNTX 162.2K
- ABVE 1.7M
- Earning Date
- CNTX 11-05-2025
- ABVE 01-01-0001
- Dividend Yield
- CNTX N/A
- ABVE N/A
- EPS Growth
- CNTX N/A
- ABVE N/A
- EPS
- CNTX N/A
- ABVE N/A
- Revenue
- CNTX N/A
- ABVE $213,446,206.00
- Revenue This Year
- CNTX N/A
- ABVE N/A
- Revenue Next Year
- CNTX N/A
- ABVE N/A
- P/E Ratio
- CNTX N/A
- ABVE N/A
- Revenue Growth
- CNTX N/A
- ABVE N/A
- 52 Week Low
- CNTX $0.49
- ABVE $0.25
- 52 Week High
- CNTX $2.59
- ABVE $4.40
- Technical
- Relative Strength Index (RSI)
- CNTX 52.03
- ABVE 44.78
- Support Level
- CNTX $0.81
- ABVE $1.82
- Resistance Level
- CNTX $0.94
- ABVE $2.07
- Average True Range (ATR)
- CNTX 0.05
- ABVE 0.15
- MACD
- CNTX -0.01
- ABVE -0.03
- Stochastic Oscillator
- CNTX 10.36
- ABVE 7.69
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About ABVE Above Food Ingredients Inc. Common Stock
Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.